Kalil G. Abdullah, MD

  • Associate Professor
  • Director, Translational Neuro-Oncology

Kalil G. Abdullah, MD, surgically treats brain tumors and specializes in minimally invasive surgical options for benign and malignant tumors of the central nervous system.
 
Dr. Abdullah is one of the few neurosurgeons in the country whose research is funded by multiple grants from the National Institutes of Health. He has been an investigator for numerous glioma studies and is actively involved in bringing promising brain tumor drugs from the laboratory to early-stage clinical trials. He has published more than 100 research articles including scientific advances in journals such as Neuro-Oncology, Cancer Cell, Nature Medicine, and Nature.

Dr. Abdullah earned his medical degree at the Cleveland Clinic Lerner College of Medicine where he was a National Institutes of Health Howard Hughes Medical Institute Scholar. He completed a residency in neurological surgery at the University of Pennsylvania and then received advanced training in neurosurgical oncology through a fellowship at the Wellington Hospital in New Zealand. He completed an additional postdoctoral research fellowship in stem cell biology at the University of Pennsylvania and holds a master’s degree from the London School of Economics.

Specialized Areas of Interest

Brain tumors, hydrocephalus.

Board Certifications

Diplomate, American Board of Neurological Surgeons

Hospital Privileges

UPMC Presbyterian
UPMC Shadyside

Professional Organization Membership

American Association of Neurological Surgeons
Congress of Neurological Surgeons
Pennsylvania Neurosurgical Society
Society for Neuro-Oncology

Professional Activities

Tissue and Biospecimen Steering Committee, Glioma Therapeutics Network, NCI
Co-Chair, Scientific Session of the AANS/CNS Brain Tumor Section
Children’s Brain Tumor Network Scientific Committee
Oligodendroglioma Proteomics Analysis Working Group, CPTAC/NCI
Reviewer, Center for Scientific Review, NIH

Education & Training

  • MD, Cleveland Clinic, 2012
  • Postdoc Fellow, University of Pennsylvania, 2017
  • Clinical Fellow, Wellington Regional Hospital, New Zealand, 2018
  • MSc, Health Economics, Policy, and Management, London School of Economics, 2019
  • Neurosurgery Residency, University of Pennsylvania, 2012-19

Honors & Awards

  • Eugene P. Frenkel Scholar in Clinical Medicine, UT Southwestern, 2021
  • Early Clinical Investigator Award, Cancer Prevention and Research Institute of Texas, 2021
  • Emerging Investigator Award, Academy of Neurological Surgeons, 2020
  • Rising Star Award, Texas Super Doctors, 2019, 2020
  • Howard Hughes Medical Institute Scholar, National Institutes of Health, 2008

Research Activities

The focus of Dr. Abdullah’s Translational Neuro Oncology Laboratory is to identify new targets for the treatment of malignant brain tumors. He focuses on brain tumor metabolism, or the way in which tumor cells use nutrients to grow and spread. By identifying critical metabolites, researchers can develop drugs to stop or slow the spread of brain cancer. To do this, research is conducted on sophisticated models of the brain, with the goal to move promising drugs to clinical trial. 

Media Appearances

Vulnerability in Brain Tumors May Open Door to New Treatments
National Cancer Institute
September 26, 2022